Cite
HARVARD Citation
Croop, R. et al. (2019). Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet. 394 (10200), pp. 737-745. [Online].